Foley Hoag Represents Pear Therapeutics in $20M Series D Extension
March 05, 2021
Foley Hoag LLP represented Pear Therapeutics, Inc., a pioneer of prescription digital therapeutics (PDTs), in the extension of its Series D financing, which included a leading national Integrated Delivery Network (IDN) as a new strategic investor. The national IDN invested $20 million, bringing the total Series D investment to $100 million. Pear is using its Series D financing to accelerate reimbursement coverage for its three FDA-authorized products, creating the first market access pathway in the PDT industry.
With offices in Boston, MA, Research Triangle, NC and San Francisco, CA, Pear aims to redefine medicine by discovering, developing and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. The company has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA.
Foley Hoag attorneys David Broadwin, Jennifer Lichtman, Anna Snook and Alexandra Bender represented Pear in the transaction.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
